Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annual Review of Sex Research|August 18, 2006
How do pharmaceutical companies approach data from sexual health studies for regulatory agencies?Maria Dilleen, Scott Haughie
Statistics in Medicine|March 11, 2003
Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervalsMaria Dilleen, Günter Heimann, Ian Hirsch
Intensive Care Medicine|November 12, 2010
Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart diseaseAlain Fraisse, Ghazwan Butrous, Mary B Taylor, et al.
The Journal of Sexual Medicine|January 21, 2006
A multinational population survey of intravaginal ejaculation latency timeMarcel D Waldinger, Paul Quinn, Maria Dilleen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 20, 2018
Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysisJohn R Hurst, Maria Dilleen, Kevin Morris, et al.
Arthritis Research & Therapy|May 31, 2018
Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patientsKatie L Druce, Laraine Aikman, Maria Dilleen, et al.
BMC Medical Research Methodology|July 14, 2016
Protecting patient privacy when sharing patient-level data from clinical trialsKatherine Tucker, Janice Branson, Maria Dilleen, et al.
The Journal of Pediatrics|October 20, 2009
Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertensionRobin H Steinhorn, John P Kinsella, Christine Pierce, et al.
Clinical Endocrinology|October 27, 2015
A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) StudyJean De Schepper, Johan Vanderfaeillie, Primus-E Mullis, et al.
Future Oncology (London, England)|October 9, 2024
Real-world effectiveness of first- and second-line anti-angiogenesis therapy in RCC: analysis of a UK-based populationTom Waddell, Manon Pillai, Kate Armitage, et al.
Pageof 1